Service de Génétique Médicale, Unité de Génétique Clinique, CHU de Nantes, Nantes, France.
Département de Génétique Médicale, CHRU Montpellier, Faculté de Médecine de Montpellier-Mimes, Université Montpellier 1, Inserm U1183, Montpellier, France.
Genet Med. 2016 Jan;18(1):49-56. doi: 10.1038/gim.2015.29. Epub 2015 Mar 19.
Treacher Collins/Franceschetti syndrome (TCS; OMIM 154500) is a disorder of craniofacial development belonging to the heterogeneous group of mandibulofacial dysostoses. TCS is classically characterized by bilateral mandibular and malar hypoplasia, downward-slanting palpebral fissures, and microtia. To date, three genes have been identified in TCS:,TCOF1, POLR1D, and POLR1C.
We report a clinical and extensive molecular study, including TCOF1, POLR1D, POLR1C, and EFTUD2 genes, in a series of 146 patients with TCS. Phenotype-genotype correlations were investigated for 19 clinical features, between TCOF1 and POLR1D, and the type of mutation or its localization in the TCOF1 gene.
We identified 92/146 patients (63%) with a molecular anomaly within TCOF1, 9/146 (6%) within POLR1D, and none within POLR1C. Among the atypical negative patients (with intellectual disability and/or microcephaly), we identified four patients carrying a mutation in EFTUD2 and two patients with 5q32 deletion encompassing TCOF1 and CAMK2A in particular. Congenital cardiac defects occurred more frequently among patients with TCOF1 mutation (7/92, 8%) than reported in the literature.
Even though TCOF1 and POLR1D were associated with extreme clinical variability, we found no phenotype-genotype correlation. In cases with a typical phenotype of TCS, 6/146 (4%) remained with an unidentified molecular defect.
Treacher Collins/Franceschetti 综合征(TCS;OMIM 154500)是一种颅面发育障碍,属于下颌面骨发育不全的异质性组。TCS 的特征经典表现为双侧下颌骨和颧骨发育不良、眼睑裂向下倾斜以及小耳。迄今为止,已在 TCS 中鉴定出三个基因:TCOF1、POLR1D 和 POLR1C。
我们报告了一项针对 146 例 TCS 患者的临床和广泛分子研究,包括 TCOF1、POLR1D、POLR1C 和 EFTUD2 基因。研究了 TCOF1 和 POLR1D 之间的 19 种临床特征的表型-基因型相关性,以及 TCOF1 基因中的突变类型或其定位。
我们在 92/146 例(63%)患者中发现了 TCOF1 内的分子异常,在 9/146 例(6%)患者中发现了 POLR1D 内的分子异常,在 POLR1C 内未发现异常。在非典型阴性患者(伴有智力障碍和/或小头畸形)中,我们发现 4 例患者携带 EFTUD2 突变,2 例患者携带 5q32 缺失,特别是包含 TCOF1 和 CAMK2A。TCOF1 突变患者的先天性心脏缺陷发生率(7/92,8%)高于文献报道。
尽管 TCOF1 和 POLR1D 与极端临床变异性相关,但我们未发现表型-基因型相关性。在 TCS 具有典型表型的病例中,6/146(4%)仍存在未识别的分子缺陷。